PRELIMINARY PROGRAM

Time

3 June 2026

08:30 - 10:00

Postgraduate courses - 4 courses - Session 1

Silfurberg

Palliative care for non-cancer

From early symptoms to end-of-life care: The spectrum of palliative treatment in severe lung diseases

Chair I: Brynja Jónsdóttir, Iceland

Chair II: Anders Blomberg, Sweden

08:30-09:00

Treatment of dyspnea in end-stage lung diseases (oxygen and opioids)

Zainab Ahmadi (Sweden)

09:00-9:30

Early integration of palliative care in non-cancer end-stage lung diseases

Annica Mansfeld (Sweden)

09:30-10:00

End-of-life treatment in hospital settings in patients with end-stage lung disease.

Arna Dögg Einarsdóttir (Iceland)

Kaldalón

Asthma

Chair: Dóra Lúðvíksdóttir (Reykjavík, Iceland)

08:30-8:50

Introduction

Dóra Lúðvíksdóttir (Iceland)

08:50 - 9:30

Case presentation. Workup and treatment of severe asthma

Speaker to be confirmed

09:30- 10:00

Head-to-head comparison of biologics in severe asthma

Unnur Steina Björnsdóttir (Iceland)

Ríma

Restrictive lung diseases

Chair I: Sigurður Þór Sigurðarson (Reykjavík, Iceland)

Chair II: Gunnar Guðmunsson (Reykjavik, Iceland)

08:30-08:50

Introduction and ILD classification

Össur Ingi Emilsson (Iceland)

08:50-09:10

Pattern-based description of HRCT

Helgi Jónsson (Iceland)

09:30-10:00

IPF diagnostic, treatment and exacerbations

Saher B Sahker (Denmark)

Vísa

COPD

Chair I: Össur Ingi Emilsson (Iceland)

Chair II: Mirjam Ljunggren (Sweden)

08:30 – 09:15

Importance of comorbidities in COPD (incl. 10min questions)

(Sigrid Anna Aalberg Vikjord) (Norway)

09:15 – 10:00

Treatment of COPD exacerbations (incl. 10min questions)

Pradeesh Sivapalan (Denmark)

10:00 - 10:30

Coffee

10:30 - 12:00

Postgraduate courses - 4 courses - Session 2

Silfurberg

Palliative care for non-cancer

10:30-11:00

Use of NIV (non-invasive ventilation) in palliative settings

Anita K Simonds MD FRCP FERS (England)

11:00-11:20

Promoting a Palliative Approach: Withdrawal of Mechanical Ventilation at Patient Request – the UK experience

Alison Armstrong (England)

11:20 - 11:40

Quality of life in long-term ventilation patients

Anna Louise Kleiven (Norway)

11:40-12:00

Panel discussion

Moderator: Bryndís Stefanía Halldórsdóttir (Reykjavík, Iceland)

Kaldalón

Asthma

10:30 -10:50

Do Comorbidities Influence the Response to Biologics in Severe Asthma?

Ramesh Kurukulaaratchy (England)

10:50-11:20

How do we define asthma remission

Alan Altraja (Estonia)

11:20 -11:40

The use of databases in a severe asthma clinic DSAR

Susanne Hansen (Denmark)

11:40-12:00

Discussion

Ríma

Restrictive lung diseases

10:30 - 10:50

ILD diagnostic

Marija Kotevska (Sweden)

10:50 - 11:20

CTD ILD

Speaker to be confirmed

11:20-11:50

Hypersensitivity pneumonitis

Tomas Eagan (Norway)

11:50- 12:00

Panel discussion

Vísa

COPD

Chair I: Össur Ingi Emilsson (Reykjavík, Iceland)

Chair II: Mirjam Ljunggren (Uppsala Sweden)

10:30– 10:50

New treatments in COPD: Biologics

Lowie Vanfleteren (Sweden)

10:50 – 11:10

New treatments in COPD: Endobronchial valves

Lowie Vanfleteren (Sweden)

11:10 – 11.30

Ventilation treatments in acute exacerbations of COPD

Jordan Cunningham (Iceland)

11:30 – 11:50

Non-invasive ventilation in chronic respiratory failure in COPD

Jordan Cunningham (Iceland)

11:50 – 12.00

Panel discussion

12:00 - 12:45

Lunch for Postgraduate courses

12:45-13:45

Program NLC 2026

Silfurberg

Opening session:

Welcome by Congress president

Guðrún Nína Óskarsdóttir

Global impact of vulcan eruption

Professor Þorvaldur Þórðarson

13:45 - 15:15

Silfurberg

Session 1

Sleep - diagnostics and treatment

Chair I: Jordan Cunningham (Reykjavik, Iceland)

13:45- 14:15

Diagnostic

TBA

14:15-14:45

Treatment

Eva Lindberg (Sweden)

14:45-15:15

Regulations, Training and Quality Assurance

Jordan Cunningham (Iceland)

Kaldalón

Session 2

Tuberculosis

Chair I: Birgir Jóhannsson (Reykjavik, Iceland)

Chair II: Tuula Vasankari

13:45-14:05

The new short treatment for sensitive and drug-resistant TB and follow-up treatment

Agnar Bjarnson (Iceland)

14:05- 14:25

LTBI: Who to diagnose and treat

Thijs Feuth

(Finland)

14:25-14:45

TB in immunos-uppression

Judith Bruchfeld (Sweden)

14:45- 15:05

TB and migration/wars (special emphasis to Ukraine)

Askar Yedilbayev WHO

15:05-15:15

Panel discussion

Ríma

Session 3

Occupational/
environmental lung diseases

Chair I: Sigurður Þór Sigurðsson (Reykjavik, Iceland)

13:45 - 14:05

Results from the NordicWelfAir project: Air pollution and childhood asthma in Iceland

Þórarinn Gíslason (Iceland)

14:05-14:25

Lung cancer and environmental factors

Adriana Hiller (Sweden)

14:25- 14:45

Wood dust exposure and chronic respiratory disease (including ILD)

Rachel Louise Hasting (Norway)

14:45-15:15

The preconception origins of respiratory health and disease: The role of the father

Cecilie Svanes (Norway)

Vísa

Skills workshop 1

AI bronchoscopy simulation

Sponsor Ambu

Stefan Barrath

15:15 - 15:45

Coffee

15:45 - 17:15

Silfurberg

Session 4

Asthma and comorbidity

Chair: TBA

15:45-16:05

United airways revisited with biologics

Sanna Salmi (Finland)

16:05- 16:25

Asthma Beyond the Airways: Understanding Comorbidities and Clinical Impact

Charlotte Ulrik (Denmark)

16:25-16:45

Epithelial integrity in asthma and allergic disease

Unnur Steina Björnsdóttir (Iceland)

16:45-17:05

Bridging the gap – combined care

Vibeke Backer (Denmark)

17:05-17:15

Panel discussion

Kaldalón

Session 5

Invasive pulmonology

Chair I: Hrönn Harðardóttir

Chair II: Per Martin Silverborn (Gothenborg, Sweden)

15:45- 16:15

EBUS in lung cancer diagnostics

Marija Kotevska (Sweden)

16:15-16:45

Bronchopulmonal fistula and Valve treatment

Stefan Barath (Sweden)

16:45-17:15

Surgical treatment for lung cancer, new technology:

Per Martin Silverborn (Sweden)

Ríma

Session 6

Case presentation

Selected from submitted cases

17:15 - 19:00

Get-together at the conference venue

– optional

Time

4 June 2026

08:30 - 10:00

Silfurberg A

Session 7

Severe asthma

Chair: Dóra Lúðvíksdóttir (Reykjavik, Iceland)

08:30-08:50

“Learnings from Nordstar” a summary of the key findings from

Nordic data on severe asthma. ( eosinophil vs non eosinophilic asthma)

Lauri Lethimaki (Finland)

08:50-09:10

Multimorbitity in severe asthma

Ramesh Kurukulaaratchy (England)

09:10-09:30

Reframing Remission in Severe Asthma - distinguishing disease activity vs damage or The Biology of remission on Biologics

Celeste Porsbjerg (Denmark)

09:30- 09:50

Severe asthma and remission prospects in Europe: insights from SHARP

Apostolos Bossios (Sweden)

09:50-10:00

Questions

Silfurberg B

Session 8

Lung Cancer Screening

Chair I: Hrönn Harðardóttir (Reykjavik, Iceland)

Chair II: Stefan Barrath (Lund, Sweden)

08:30-09:00

Screening in the UK

David Baldwin (England)

09:00-09:20

Screening in Norway

Oluf Dimitri Roe (Norway)

09:20-09:40

Screening in Estonia

Tanel Laisaar (Estonia)

09:40-10:00

Screening in Sweden

Gunnar Wagenius (Sweden)

Kaldalón

Session 9

Respiratory insufficiency

Chair I: Friðrik Yngvason (Reykjavík, Iceland)

Chair II: Christina Due Svendsen (Bergen, Norway)

08:30-08:50

Use of NHFT in chronic respiratory failure

Ulla M Weinreich (Denmark)

08:50-09:20

LTOT and hypoxemia is less better?

Magnus Ekström (Sweden)

09:20-09:40

Lung diseases and acute respiratory failure: when to intubate and the challenges in treatment.

Helga Ásgeirsdóttir (Sweden)

09:40-10:00

Panel discussion

Ríma

Nurse session 1

Nurse-Patient Relationship

Chair: Helga Jónsdóttir (Reykjavik, Iceland)

Stigma and Vulnerability in the Care of Patients with COPD

Heidi Jerpseth (Norway)

Relational Continuity in COPD Care: Insights from Patients in Swedish Primary Care. A qualitative study

Sara C. Roos (Sweden)

Understanding COPD-related anxiety: Experiences of patients, caregivers and healthcare professionals

Camilla F. Christiansen (Denmark)

Co-Creating a Differentiated Intervention for People with COPD in Socially Vulnerable Situations

Nanna V. Gregersen (Denmark)

10:00 - 10:30

Coffee

10:30 - 12:00

Silfurberg A

Session 10

Sanofi - Symposium

TBA

Silfurberg B

Session 11

Pulmonary hypertension

Chair I: Sif Hansdóttir (Reykjavik, Iceland)

Chair II: Rainer Böger (Germany)

10:30-11:00

Risk stratification and treatment goals in PAH - Reflections on the new WSPH treatment algorithm

Göran Rådegran (Sweden)

11:00-11:30

Borderline or Overlap? Defining PH Phenotypes in Patients With Multiple Comorbidities

Clara Hjalmarsson (Sweden)

11:30-12:00

CTEPH

Sören Mellemkjær (Denmark)

Kaldalón

Session 12

Pulmonary Rehabilitation: Accessibility, participation and maintenance

Chair: TBA

10:30-11:00

Referral, uptake, adherence and maintenance

Margareta Emtner (Sweden)

11:00-11:20

Home-based and tele-rehabilitation programmes for socially or geographically isolated patients

Henrik Hansen (Denmark)

11:20-11:40

Long-term maintenance training in Iceland

Ragnheiður Harpa Arnardóttir (Iceland)

11:40-12:00

Panel discussion

Ríma

Nurse session 2

Patients’ Experiences of Treatments

Chair: Þorbjörg Sóley Ingadóttir (Reykjavik, Iceland)

Everyday life with Ambulatory Oxygen Treatment in Patients with COPD

Ann Ekdahl (Sweden)

Telehealth for patients with COPD-Birgit Refsgaard Iversen

Birgit Refsegaard Midjord (Denmark)

Asthma/COPD clinics in primary care adherence to non-pharmacological management guidelines in patients with COPD

Jenny Nilsson (Sweden)

12:00 - 13:00

Lunch

12:10 - 13:00

Silfurberg A

GSK Symposium

TBA

Silfurberg B

Astra Zeneca – Symposium

TBA

13:00 - 14:30

Silfurberg A

Session 13

COPD

Chair I: Benedikt Friðriksson

Chair II: Christer Jansson (Uppsala, Sweden)

13:00-13:20

Dyspnea in COPD: mechanisms, measurement and management

Magnus Ekström (Sweden)

13:20-13:40

Application of endobronchial valves in treatment of COPD

Lowie Vanfleteren (Sweden)

13:40-14:00

Use of biologics in treatment of COPD

Lowie Vanfleteren (Sweden)

14:00-14:20

On the importance of vaccinations in patients with COPD - a 2026 update.

Eva van Braeckel (Belgium)

Silfurberg B

Session 14

Bronchiectasis

Chair Inga Sif Ólafsdóttir (Reykjavik, Iceland)

Case based interactive session with multidisciplinary panel

Speakers to be announced later

Kaldalón

Session 15

Lung transplantation

Chair: Sif Hansdóttir (Reykjavik, Iceland)

13:00- 13:20

„A perfect match?“

Sigrún Ásgeirsdóttir (Iceland)

13:20-13:40

ABC, CLAD and the proposed other LAD‘s

Jesper Magnusson (Sweden)

13:40-14:00

Lung transplantation surgery, new technology

Per Martin Silverborn (Sweden)

14:00-14.20

Panel discussion/Questions

14:30 - 15:00

Coffee break / Poster Rounds

15:00 - 16:30

Silfurberg A

Session 16

The role of screening for obstructive diseases and treatment adherence

Chair: TBA

15:00- 15:20

How Common Is Obstructive Sleep Apnea in the General Population? Is It Time to Start General Screening?

Elín Helga Þórarinsdóttir (Iceland)

15:20-15:40

Results from the BreatheIn asthma

Kristina Kock Hansen (Denmark)

15:40-16:00

Results from the BreatheIn COPD

Anders Løkke ( Denmark)

Silfurberg B

Session 17

Chronic cough

Chair: Össur Ingi Emilsson

15:00 - 15:30

Defining chronic cough – is there a need for change?

Anne Lätti (Finlnd)

15:30– 16:00

Current standards in the treatment of cough

Össur Ingi Emilsson (Iceland), Henrik Johansson (Sweden)

16:00 - 16:30

NeuroCough: New insights in chronic cough from multi-center registries

Lorcan McGarvey (Ireland)

Kaldalón

Session 18

Sleep and respiration in Neuromuscular diseases

Chair I: Sólrún Björk Rúnarsdóttir (Reykjavik, Iceland)

15:00- 15:20

Tracing History Through Registers: A Retrospective Inquiry

Andreas Palm (Sweden)

15:20-15:40

Sleep and breathing in neuromuscular diseases

Sigurd Aarrestad (Norway)

15:40-16:00

Use of mechanical insufflation/ exsufflation in patients with neuromuscular diseases

Tiina Andersen (Norway)

16:00-16:20

LTMV in NMD invasive vs non-invasive (indications/
advantages/ disadvantages

Anita Simmonds (England)

16:35 - 17:35

NORA meeting

Chair: Gunnar Guðmundsson

Agenda: Teaching Respiratory Medicine to Medical Students in the New Era and NLC 2028

Time	5 June 2026
08:30 - 10:00	Silfurberg A Session 19 What is happening in the Nordics and Europe- Scientific researches Chair I: Þórarinn Gíslason (Reykjavik, Iceland) Chair II: Christer Jansson (Uppsala, Sweden) 08:30 - 08:50 Burden of obstructive lung disease - BOLD/ André Amaral (England) 08:50 - 09:10 Burden beyond the lungs: patient-reported experiences of COPD in five European countries Anders Løkke (Denmark) 09:10 - 09:30 SCAPIS project Andrei Malinovschi (Sweden) 09:30 - 09:50 Hypoxic pulmonary vasoconstriction as a driver of cardiopulmonary disease – Steps towards identification of novel targets for treatment of COPD Rainer Böger ( Germany)	Silfurberg B Session 20 Tobacco prevention Chair I: TBA Chair II: Jónína Sigurgeirsdóttir 08:30-09:00 The new nicotine epidemic Charlotta Pisinger (Denmark) 09:00-09:30 Health effects of novel nicotine products Magnus Lundbäck (Sweden) 09:30-10.00 Treatment of tobacco dependence – an experience from Iceland Jónína Sigurgeirsdóttir (Iceland)	Kaldalón Physiotherapy Session A Breathing exercises and mobilization; for whom, how and why? Chair I: Ragnheiður Harpa Arnardóttir Chair II: Ólöf Ragna Ámundadóttir 08:30-08:50 Clinical reasoning in respiratory physiotherapy Monika Fagevik Olsén (Sweden) 08:50-09:10 Early mobilization after abdominal and cardiothoracic surgery Monika Fagevik Olsén (Sweden) 09:10-09:30 PEP: History, applications and physiological effects Monika Fagevik Olsén (Sweden) 09:30-09:50 Revisiting assumptions about the dependent-lung ventilation during airway clearance techniques: did we target the wrong lung William Poncin (Belgium) 09:50-10:00 Panel discussion	Ríma Session 21 Poster symposium/ Young researchers TBA
10:00 - 10:30	Coffee / Poster rounds
10:30 - 12:00	Silfurberg A Session 22 Cutting-edge Insights from the European Clinical Respiratory Journal: The Year's Most Influential Scientific Papers Chair: Vasiliki Panou (Denmark)	Silfurberg B Session 23 Interstitial lung diseases Chair I: Gunnar Gudmundsson (Reykjavik, Iceland) Chair II: Zainab Ahmadi (Lund, Sweden) 10:30-11:00 CTD-ILD Elisabeth Bendstrup (Denmark) 11:00-11:30 Early and familial pulmonary fibrosis Matt Hunninghake (USA) 11:30-12:00 Sarcoidosis Tomas Eagan (Norway)	Kaldalón Physiotherapy Session B Physical training in COPD and asthma, various approaches 10:30-11:00 Physical training in asthma and COPD Margareta Emtner (Sweden) 11:00-11:20 Is HIT a HIT in COPD? André Nyberg (Sweden) 11:20-11:40 Oxygen on the Move: Optimising Oxygenation to Improve Functional Performance in COPD Linette Marie Kofod (Denmark) 11:40-12:00 Panel discussion	Ríma Session 24 Poster session/Young researchers
12:00 - 13:00	Closing remarks

Congress secretariat

Athygli ráðstefnur

Athygli Conferences

Kristjana Magnúsdóttir
Phone: +(354) 820 4339
Email: kristjana@atconferences.is

© 2026, Athygli Conferences